The Effects of a Mediterranean Diet in Pediatric Hyperlipidemia (EARLYMedit)
Primary Purpose
Hyperlipidemia
Status
Completed
Phase
Phase 1
Locations
United States
Study Type
Interventional
Intervention
Omega-3 fatty acid (Eicosapentaenoic acid)
Sponsored by
About this trial
This is an interventional prevention trial for Hyperlipidemia focused on measuring endothelial function, lipids, pediatrics
Eligibility Criteria
Inclusion Criteria:
- Children (8-17 years old)
- Familial Hypercholesterolemia or Familial Combined Hyperlipidemia
- Able to read, write and understand English
- Parental consent and child assent
- Access to a computer and internet and literacy in the use of the internet
- The attendance of a parent to each educational session.
Exclusion Criteria:
- Chronic systemic illness with or without secondary hyperlipidemia
- Current smoking
Sites / Locations
- University of California, San Francisco
Outcomes
Primary Outcome Measures
Endothelial function
Secondary Outcome Measures
Full Information
NCT ID
NCT01308710
First Posted
March 3, 2011
Last Updated
January 23, 2014
Sponsor
University of California, San Francisco
Collaborators
Vanderbilt University, Tufts University, University of Guelph, University of L'Aquila
1. Study Identification
Unique Protocol Identification Number
NCT01308710
Brief Title
The Effects of a Mediterranean Diet in Pediatric Hyperlipidemia
Acronym
EARLYMedit
Official Title
Endothelial Assessment of Risk From Lipids in Youth: Mediterranean Diet
Study Type
Interventional
2. Study Status
Record Verification Date
January 2014
Overall Recruitment Status
Completed
Study Start Date
January 2010 (undefined)
Primary Completion Date
July 2011 (Actual)
Study Completion Date
July 2011 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of California, San Francisco
Collaborators
Vanderbilt University, Tufts University, University of Guelph, University of L'Aquila
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Children with high cholesterol levels are especially vulnerable and are at high risk for early onset coronary heart disease (CHD). Endothelial dysfunction, the earliest phase of CHD, is present in children with elevated cholesterol levels as early as 8 years of age. The long term objective of this study is to develop dietary interventions for the prevention and treatment of endothelial dysfunction in children with common lipid disorders including familial hypercholesterolemia (FH) and familial combined hyperlipidemia (FCH). Increasing evidence suggests that the Mediterranean diet and ω-3 fatty acids found in fish have cardioprotective effects. The specific aims of the study are to: determine whether a Mediterranean diet alone or combined with ω-3 fatty acid (eicosapentaenoic acid)improves endothelial function; evaluate the effects of the dietary interventions on lipids and lipoprotein subclasses; evaluate the effects of the dietary interventions on biomarkers for oxidative stress and inflammation. This study is a randomized, double-blind, placebo-controlled clinical trial that includes 34 children (ages 8-17) treated with the Mediterranean diet and ω-3 fatty acid supplements. A dietary educational behavioral intervention will be conducted over 6 months with individual counseling and group sessions. Endothelial function will be measured noninvasively by high resolution ultrasound of the brachial artery at baseline, 6, 12, 18 and 24 weeks. This study is unique because it is a new intervention designed for children at high risk for early CHD with a dietary component and supplementation with ω-3 fatty acids. If effective, this intervention would be broadly applicable in the community and lend valuable insight about dietary therapy to prevent the progression of CHD in hyperlipidemic children.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hyperlipidemia
Keywords
endothelial function, lipids, pediatrics
7. Study Design
Primary Purpose
Prevention
Study Phase
Phase 1
Interventional Study Model
Crossover Assignment
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
10 (Actual)
8. Arms, Groups, and Interventions
Intervention Type
Dietary Supplement
Intervention Name(s)
Omega-3 fatty acid (Eicosapentaenoic acid)
Other Intervention Name(s)
PlusEPA
Intervention Description
1.0 grams daily for 6 weeks
Primary Outcome Measure Information:
Title
Endothelial function
Time Frame
Measured every 6 wks for 6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
8 Years
Maximum Age & Unit of Time
17 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Children (8-17 years old)
Familial Hypercholesterolemia or Familial Combined Hyperlipidemia
Able to read, write and understand English
Parental consent and child assent
Access to a computer and internet and literacy in the use of the internet
The attendance of a parent to each educational session.
Exclusion Criteria:
Chronic systemic illness with or without secondary hyperlipidemia
Current smoking
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marguerite M. Engler, PhD
Organizational Affiliation
University of California, San Francisco
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Mary B. Engler, PhD
Organizational Affiliation
University of California, San Francisco
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of California, San Francisco
City
San Francisco
State/Province
California
ZIP/Postal Code
94143
Country
United States
12. IPD Sharing Statement
Learn more about this trial
The Effects of a Mediterranean Diet in Pediatric Hyperlipidemia
We'll reach out to this number within 24 hrs